个人简介
工作经历
2010.9 - 2015.6，安徽医科大学，预防医学专业，本科
2015.9 - 2018.6，复旦大学，流行病与卫生统计学专业，硕士
2018.9 - 2021.6，复旦大学，遗传学专业，博士
2021.6 - 2023.12，复旦大学人类表型组研究院，博士后
2023.12 至今，复旦大学人类表型组研究院，青年研究员
获奖情况
2018、2021年，上海市优秀毕业生
2020年，复旦大学学术之星
2021年，第六届“博新计划”
2021年，上海市“超级博士后”
研究领域
慢性肝脏疾病（脂肪肝、病毒性肝炎、肝癌）分子/遗传流行病学
近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Liu Z#, Jiang Y#, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019; 70(4): 674–683.
Liu Z#, Mao X#, Wu J#, et al. World-wide prevalence of substitutions in HCV genome associated with resistance to direct-acting antiviral agents. Clin Gastroenterol Hepatol. 2021; 19 (9): 1906-1914.
Liu Z#, Xu K#, Jiang Y, et al. Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study. Int J Epidemiol. 2021;50(1): 128-142.
Liu Z#, Suo C#, Shi O, et al. The health impact of MAFLD, a novel disease cluster of NAFLD, is amplified by the integrated effect of fatty liver disease-related genetic variants. Clin Gastroenterol Hepatol. 2022; 20(4): e855-e875.
Liu Z#, Lin C#, Suo C#, et al. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metabolism. 2022; 127:154955.
Liu Z, Suo C, Fan H, et al. Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases. Metabolism. 2022; 135:155270.
Liu Z#, Song C#, Suo C, et al. Alcohol consumption and hepatocellular carcinoma: novel insights from prospective cohort study and nonlinear Mendelian randomization analysis. BMC Med. 2022; 20:413.
Liu Z#, Lin C#, Mao X#, et al. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 2023, 72(12):2354-2363.
京公网安备 11010802027423号